Home / Clinical Guideline Hubs / Chapter 5.3
Section 5 — General NICU Care / Supportive Care Verify against local policy v1.0 · July 2026 Baylor Ed. 33 cross-checked Sept 2026

Chapter 5.3 — Neonatal Pain Assessment & Sedation

Neonates feel pain: routine validated assessment, a non-pharmacological-first approach for procedures, and judicious analgesia/sedation — built on West Midlands Neonatal Guidelines 2025–28, AAP/COFN pain prevention guidance, and validated neonatal pain scales

Educational guideline — verify locally. Opioid/sedative doses and infusion regimens must be verified against the Neonatal Formulary and local policy; these agents cause respiratory depression and tolerance. Does not replace attending judgment.
BEDSIDE ACTION BOX

1. Overview

Overview

Newborn infants have functioning nociceptive pathways and experience pain; repeated untreated pain is associated with physiological instability and adverse neurodevelopmental effects. Modern neonatal care therefore prevents and minimizes pain, assesses it routinely with validated tools, and treats it with a non-pharmacological-first, stepwise approach — reserving opioids and sedatives for significant pain and using them judiciously because of respiratory depression, tolerance, and withdrawal.

Why This Topic Matters

Under-treated pain harms the developing brain and destabilizes the infant; over-sedation causes respiratory depression, hypotension, tolerance, and iatrogenic withdrawal. A structured, assessed, stepwise approach balances comfort and safety.

2. Who This Guideline Applies To

Scope
  • All neonates undergoing painful procedures or with acute/ongoing pain (post-operative, ventilated, chest drains, NEC).
  • Infants receiving opioid/sedative infusions and those being weaned from them.
  • Cross-references: developmental care (5.1), neonatal opioid withdrawal (5.4), and post-operative/surgical care (Section 11).

3. Key Definitions

TermDefinition
Validated pain scaleA tool scoring behavioral/physiological indicators (e.g., PIPP-R, N-PASS, NIPS, COMFORTneo).
Non-pharmacological analgesiaComfort measures (breast milk, sucrose, sucking, tucking, skin-to-skin) reducing pain response.
AnalgesiaRelief of pain (e.g., opioids, paracetamol).
SedationReduction of agitation/awareness (e.g., benzodiazepines) — not analgesia.
Iatrogenic withdrawalWithdrawal from prolonged opioid/sedative use — wean gradually (see 5.4).

4. Pain Assessment

Assess Routinely with a Validated Tool
  • Use a validated, gestation-appropriate scale (e.g., PIPP-R for procedural pain, N-PASS for ongoing pain/sedation) at regular intervals and around procedures.
  • Indicators include facial expression (brow bulge, eye squeeze, nasolabial furrow), cry, body movement/tone, and physiological changes (heart rate, oxygen saturation).
  • Remember that the sickest/most preterm infants may show blunted responses — a low score does not always mean no pain.
  • Document scores and the response to interventions.

5. Non-Pharmacological Measures (First-Line)

Use for Every Procedure
  • Breastfeeding or expressed breast milk during procedures; oral sucrose or glucose with non-nutritive sucking (a pacifier) for procedural pain.
  • Facilitated tucking / swaddling / containment, skin-to-skin (kangaroo) care, and a calm, low-stimulation environment.
  • Minimize the number of painful procedures; use the least painful technique; cluster cares and involve parents.

6. Procedural Pain

Match the Approach to the Procedure
  • Minor procedures (heel prick, venepuncture, cannulation): non-pharmacological measures ± sucrose/breast milk; consider topical/local anesthetic where appropriate.
  • More invasive procedures (chest drain, lumbar puncture, intubation): add analgesia or premedication.
  • Premedicate every non-emergency intubation — atropine and fentanyl (± midazolam from 44 weeks PMA), then vecuronium (doses in the table below).
Intubation: premedication and safety (Baylor Ed. 33)
  • Why it matters: an emergent intubation carries four times the odds of an adverse event of a planned one, and more attempts mean more hypotension, bradycardia and desaturation. In VLBW infants, more attempts are also linked to severe IVH. An attempt is counted from the moment the blade enters the oropharynx. Limit each attempt to 30 seconds, premedicate whenever possible, and brief the team in advance.
  • Preparation: discuss indication, risks and benefits; check for a "critical airway" label and agree who to call (e.g., the difficult-airway team or ENT) if it fails; assign roles; choose the tube size and depth; check equipment and have the drugs drawn up.
  • Video laryngoscopy, where available, may raise first-attempt success and slightly reduce attempts (low certainty) and airway adverse events (moderate certainty), but may not shorten time to intubation.
  • Premedication is appropriate for any non-emergent intubation. Omitting it is acceptable only during active resuscitation or when the infant is not stable on current support.
Premedication (Baylor, based on 2023 NeoReviews)IV dosePurpose
Atropine0.02 mg/kg IV pushVagolytic — reduces bradycardia and secretions
Fentanyl1–2 mcg/kg IV infused over 5 min (LISA/InSurE: 0.5–1 mcg/kg)Analgesia and sedation
Midazolam (if needed; 44 weeks PMA or older only)0.1 mg/kg IV over 2 minAdditional sedation
Vecuronium0.08–0.1 mg/kg IV push, only after adequate sedationReduces movement. Not used for LISA or InSurE, so the infant can breathe or be extubated early
No IV accessFentanyl 1.5 mcg/kg intranasal (undiluted) ± midazolam 0.2 mg/kg intranasal (≥44 weeks PMA) ± succinylcholine 2 mg/kg IMSame goals
Premedication hazards
  • Fentanyl chest-wall rigidity: avoid it with correct doses and slow infusion. If it occurs, give vecuronium 0.1 mg/kg IV; if it persists, consider a second dose or naloxone.
  • Cannot intubate after paralysis: keep ventilating by face mask or laryngeal mask. Short-acting agents can be reversed with neostigmine.
  • Succinylcholine is listed by Baylor as contraindicated in preterm infants and in hyperkalaemia, cardiac disease or myopathy.
Weight / PMA (Baylor Table 16-3)Tube size (ID, mm)
<1 kg or 22–27 weeks2.0 or 2.5
1 to <2 kg or 28–34 weeks3.0
≥2 kg or ≥35 weeks3.5
Post-term or larger infants4.0
Opioid infusions and scoring tools (Baylor Ch 19.4–19.5)
  • Starting infusions: morphine 0.01 mg/kg/h or fentanyl 0.5–1 mcg/kg/h. If pain or sedation is inadequate by signs and score, give a bolus equal to 1 hour of the current rate, then increase by 0.01–0.02 mg/kg/h (morphine) or 1 mcg/kg/h (fentanyl), repeating every 30–60 minutes and reassessing 30–60 minutes after each change. Tolerance usually develops within 3–5 days on fentanyl and 5–7 days on morphine, so doses may need adjusting beyond those points.
  • After surgery, scheduled acetaminophen (enteral, rectal or IV) reduces opioid need; reassess its continuation every 48 hours.
  • <44 weeks PMA — N-PASS (pain and sedation, preterm-adjusted): treat pain for scores above 3; light sedation −5 to −2 is the target on continuous sedation; deep sedation (−10 to −5) is not routine and needs an explicit ordered goal.
  • ≥44 weeks PMA — CRIES plus SBS: CRIES (pain only, maximum 10) — ≤4 no or mild pain, comfort measures; ≥5 moderate–severe pain, add analgesia. SBS (sedation only) with an individual ordered goal — −2 to 0 recommended when intubated; score on admission, before and after sedatives or interventions, and at least every 4 h on continuous sedation.
  • Delirium: the Cornell Assessment of Pediatric Delirium (validated 0–21 years) when ICU delirium is suspected — scores above 9 indicate delirium; do not score at SBS −3.

7. Pain Management Algorithm

1
Anticipate & minimize
Reduce painful procedures; bundle bloods; cluster cares; plan comfort measures in advance.
2
Assess with a validated scale
Score pain around procedures and at intervals; document.
3
Non-pharmacological first
Breast milk/sucrose + sucking, tucking/swaddling, skin-to-skin for every procedure.
4
Significant/ongoing pain?
Add analgesia (paracetamol; opioids for moderate–severe pain) ± sedation per policy, with monitoring.
5
Reassess & wean
Re-score after intervention; titrate to comfort; wean opioids/sedatives gradually to avoid withdrawal (see 5.4).
6
⚠ Do-not-miss
Under-treated pain in the sickest infants (blunted scores); opioid respiratory depression/hypotension; and iatrogenic withdrawal on abrupt weaning.

8. Pharmacological Analgesia & Sedation

AgentRoleCautions
Oral sucrose/glucoseProcedural pain (with sucking).Repeated doses in ELBW — use judiciously.
ParacetamolMild–moderate pain; opioid-sparing.Dose per gestation; liver considerations.
Opioids (morphine, fentanyl)Moderate–severe/ongoing pain; ventilated/post-op.Respiratory depression, hypotension, tolerance, withdrawal, ileus.
Benzodiazepines (e.g., midazolam)Sedation (not analgesia).Respiratory depression, hypotension; avoid below 44 weeks PMA except CDH sedation (11.7); neurodevelopmental concerns.
Dosing on this page

Doses below and in section 6 follow Baylor Ed. 33 as the default. Sedatives are not analgesics — treat pain with analgesia. Check preparation and concentration against your formulary before giving.

Sucrose — the dose and the two-minute rule
  • 24% sucrose given orally about 2 minutes before the stimulus produces statistically and clinically significant reductions in pain response — the interval matters because it coincides with the endogenous opioid release the sweet taste triggers. Pain relief is greater with non-nutritive sucking as well as sucrose than with either alone.
  • Below 35 weeks corrected age: 0.2 mL/dose every 2 minutes, up to 3 doses, maximum 0.6 mL per procedure. At 35 weeks or more: 1 mL/dose every 2 minutes, up to 3 doses, maximum 3 mL per procedure. Only three series in any 24 hours without a further prescriber's order.
  • Kangaroo care reduces heel-stick pain in preterm infants from 32 weeks postmenstrual age. Facilitated tucking — holding the limbs flexed and contained close to the trunk — and non-nutritive sucking are the other non-pharmacological staples.
  • Scale of the problem: a preterm infant undergoes an average of 61 invasive procedures between admission and discharge, and the youngest or sickest may experience more than 450. Review every element of care for genuine necessity — the cheapest analgesia is the procedure not done.
OpioidRoute and dose (acute pain)Titration
Morphine sulfateIntermittent IV 0.05–0.1 mg/kg over 5–10 minutes every 4–6 hoursStart the infusion at 0.01–0.02 mg/kg/h and titrate by no more than 0.02 mg/kg/h every 30 minutes; if an increase is needed, a bolus is usually needed too.
Oral: neonates 0.08–0.1 mg/kg every 4–6 h; under 6 months 0.08–0.1 mg/kg every 3–4 h; over 6 months 0.2–0.5 mg/kg every 3–4 h
Infusion: load 0.05–0.1 mg/kg over 5 minutes, then 0.01–0.02 mg/kg/h
Fentanyl citrateIntermittent IV 1–2 mcg/kg over 5 minutes every 2–4 hours; infusion 0.5–1.0 mcg/kg/hTitrate by no more than 1 mcg/kg/h every 30 minutes.

Longer dosing intervals are often needed below 1 month of age — elimination half-lives are longer and clearance is delayed compared with older infants. Sedatives, including benzodiazepines and barbiturates, do not relieve pain and should be used only once pain has been excluded. In a paralyzed or severely neurologically impaired infant, use physiologic measures to assess pain, since paralysis masks the behavioural signs — and give analgesia. Rectal paracetamol has a longer duration of action than the intravenous route.

Weaning opioids after prolonged use
  • Short-term therapy — under 3 days of fentanyl or under 5 days of morphine — can simply be stopped, no wean needed.
  • Intermediate, 3–5 days to 2 weeks: wean before stopping, at a rate set by duration, dose and clinical factors such as pulmonary hypertension. Stop WAT-1 monitoring 48 hours after the opioid ends if scores stay ≤3.
  • Long-term — beyond 2 weeks, or a maximum of fentanyl above 10 mcg/kg/h or morphine above 0.1 mg/kg/h: wean as for intermediate, or convert to oral morphine if the infant tolerates enteral therapy and the line can come out. Be careful converting fentanyl to morphine in young infants — the conversion factors differ from those in older patients. Methadone only for infants not dependent on the opioid for sedation and needing a long wean; its long half-life makes it unsuitable for a quick one.
  • The weaning factor — the percentage being weaned multiplied by the original dose — stays fixed throughout, even as the doses shrink, and should be a straight milligram amount, not mg/kg, because the weight changes during treatment. Weaning generally takes about as long as the exposure did. Monitor with WAT-1, checking that the behaviours being scored are actually abnormal for the infant's age.
  • Defer weaning if the risk factors for pain persist, pain scores are up, or there are physical or behavioural signs of pain — treat the pain first.

9. Monitoring

ParameterWhenAction
Pain scoreRoutinely + around proceduresEscalate comfort/analgesia; document response.
Respiratory status/SpO₂On opioids/sedativesWatch for depression; support/naloxone if needed.
Blood pressureOn opioids/sedativesManage hypotension.
Bowel functionOn opioidsWatch for ileus.
Withdrawal signsDuring weaningScore and slow the wean (see 5.4).

10. Precautions

Safety Cautions
  • Do not assume the sickest/most preterm infants are pain-free — their responses can be blunted.
  • Sedatives are not analgesics — treat pain with analgesia.
  • Monitor for opioid/benzodiazepine respiratory depression and hypotension; verify doses.
  • Avoid benzodiazepine sedation below 44 weeks PMA (neurodevelopmental concerns); CDH sedation is the exception (11.7).
  • Wean prolonged opioids/sedatives gradually to prevent iatrogenic withdrawal (see 5.4).

11. Escalation & Family Support

Family-Centered Communication
  • "Babies do feel pain, so we check for it and prevent it — your milk, gentle holding, and skin-to-skin all help during tests."
  • "For bigger procedures or after surgery we use pain medicines carefully, watching breathing closely, and reduce them slowly when no longer needed."

12. Key Pearls

High-Value Clinical Pearls
  • Neonates feel pain — assess routinely with a validated scale and prevent it.
  • Non-pharmacological measures first for every procedure (breast milk/sucrose + sucking, tucking, skin-to-skin).
  • Minimize painful procedures; use the least painful technique; cluster cares.
  • Sedation ≠ analgesia; treat pain with analgesia.
  • Opioids for moderate–severe pain; monitor for respiratory depression/hypotension.
  • Wean prolonged opioids/sedatives gradually to avoid iatrogenic withdrawal.

13. Common Mistakes to Avoid

MistakeWhy it harmsBetter practice
Assuming neonates don't feel pain.Untreated pain harms.Assess and treat routinely.
Skipping non-pharmacological measures.Avoidable distress.Breast milk/sucrose + sucking, tucking.
Using sedation for pain.Pain untreated; over-sedation.Analgesia for pain; sedation only if indicated.
Unmonitored opioids.Respiratory depression.Monitor respiration/BP; verify doses.
Abrupt weaning.Iatrogenic withdrawal.Gradual wean; score withdrawal (5.4).

14. Board-Style High-Yield Summary

Key Takeaways
  • Neonates feel pain; assess routinely with validated scales (PIPP-R, N-PASS).
  • Prevent and minimize painful procedures; non-pharmacological measures first (breast milk/sucrose + sucking, tucking, skin-to-skin).
  • Sedation is not analgesia — treat pain with analgesia (paracetamol; opioids for moderate–severe pain).
  • Monitor opioids/sedatives for respiratory depression and hypotension; verify doses.
  • Avoid benzodiazepine sedation below 44 weeks PMA, except CDH sedation (11.7).
  • Wean prolonged opioids/sedatives gradually to prevent iatrogenic withdrawal (see 5.4).

15. References

Back to Clinical Guideline Hubs